NCT06898879 Enhancing Veteran-Clinical Collaboration in VA PRRCs
| NCT ID | NCT06898879 |
| Status | Recruiting |
| Phase | — |
| Sponsor | VA Office of Research and Development |
| Condition | Schizophrenia |
| Study Type | INTERVENTIONAL |
| Enrollment | 119 participants |
| Start Date | 2026-08-12 |
| Primary Completion | 2028-04-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 119 participants in total. It began in 2026-08-12 with a primary completion date of 2028-04-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Over 60% of Veterans with serious mental illness have a service-connected disability that impairs their ability to work, go to school, and/or have successful personal lives. Although traditional treatments tend to focus on symptom remission, Veterans prioritize a range of treatment goals, including personal empowerment and gaining personally meaningful skills. Increasing Veteran-clinician collaboration can help effectively align care with each Veteran's goals and support an empowering therapeutic experience. This project will evaluate the effectiveness of a group-based intervention intended to increase Veterans' comfort, confidence, knowledge, and skills to collaborate with their treatment teams. Findings from this study will contribute important knowledge about this intervention's effectiveness and how to enhance its effectiveness, especially for Veterans from minoritized groups. If the decision-making intervention is effective, it would help Veterans with serious mental illness, and might also help Veterans with other chronic health conditions, like PTSD and chronic pain.
Eligibility Criteria
Inclusion Criteria: 1. Be a Veteran currently receiving Psychosocial Rehabilitation and Recovery Center (PRRC), Mental Health Intensive Case Management (MHICM) and/or Behavioral Health Interdisciplinary Program (BHIP) services at VA San Diego, Los Angeles, or Albuquerque (e.g., seen in the clinic in the past month or based on clinic criteria) 2. Meet Substance Abuse and Mental Health Services Administration (SAMHSA) criteria of serious mental illness; i.e., "having (within the past year) a diagnosable mental, behavior, or emotional disorder that causes serious functional impairment that substantially interferes with or limits one or more major life activities," based on chart review and clinician consultation if needed 3. Be fluent and literate in English 4. Agree to have a subset of VA mental health treatment appointments audiotaped Exclusion Criteria: 1. Primary substance use or organic neurological disorder diagnosis determined by chart review 2. Are determined by clinician and/or study staff to be at significant risk of exacerbation of symptoms, suicidal ideation, or other risk due to study participation 3. Have a history and/or current risk of violence that clinicians and/or study staff determine to be too high risk to manage effectively in the study setting (e.g., poses a risk to Veterans or study staff)
Contact & Investigator
Emily Treichler, PhD
PRINCIPAL INVESTIGATOR
VA San Diego Healthcare System, San Diego, CA
Frequently Asked Questions
Who can join the NCT06898879 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Schizophrenia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06898879 currently recruiting?
Yes, NCT06898879 is actively recruiting participants. Contact the research team at Emily.Treichler@va.gov for enrollment information.
Where is the NCT06898879 trial being conducted?
This trial is being conducted at San Diego, United States, West Los Angeles, United States, Albuquerque, United States.
Who is sponsoring the NCT06898879 clinical trial?
NCT06898879 is sponsored by VA Office of Research and Development. The principal investigator is Emily Treichler, PhD at VA San Diego Healthcare System, San Diego, CA. The trial plans to enroll 119 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.